Progenics Pharma (PGNX) CEO Mark. R. Baker Resigns

November 12, 2019 6:26 AM

Progenics Pharma (NASDAQ: PGNX) disclosed:On November 11, 2019, Mark. R. Baker tendered his resignation as Chief Executive Officer of Progenics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found